Linkage to Care - Part I

HIV-Related Care Engagement: Linkage to Care and Care-Seeking for HIV-Infected Adolescents, Phase I

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00703040

Enrollment

Registered

2008-06-23

Start date

2008-03-31

Completion date

2010-03-31

Last updated

2017-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

Care engagement, Linkage to care, HIV Infections

Brief summary

This first phase of a two-phase study involves three components: 1. Review of existing linkage-to-care protocols and sources of referrals for care; 2. Semi-structured telephone or face-to-face interviews with a minimum of two personnel per site who are associated with linkage to medical care. (Preference will be given to personnel with direct experience in linkage to care); and 3. Structured observations of referral sessions.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* Component 1: Documents identified by clinical site personnel as pertaining to post-test counseling, linkage to care, or standard operating procedures addressing post-test counseling and linkage to care. * Component 2: Persons employed by one of the AMTUs or an identified linkage-to-care partner and work as clinical staff or a case-manager or is a person familiar to linkage to care; or persons involved in posttest counseling and linkage-to-care processes. Clinical staff and case managers are chosen based on direct experience in the assistance of HIV seropositive youth obtaining medical care. This definition includes, but is not limited to, physicians, nurses, psychologists, social workers, and case managers (who may have diverse professional backgrounds). * Component 3: All AMTU sites will be included.

Exclusion criteria

* Component 1: No a priori exclusions. * Component 2: No a priori exclusions. * Component 3: No a priori exclusions.

Design outcomes

Primary

Measure	Time frame
Describe and evaluate community screening standards and practices.	1 year
Describe and evaluate the relationships of screening venues with care-providing venues.	1 year
Describe and evaluate referral and intake protocols.	1 year
Describe and evaluate care adherence support (including support from both clinical and non-clinical sources).	1 year

Countries

United States

Outcome results